DH 📈 Definitive Healthcare - Overview

Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US24477E1038

DH: Healthcare, Data, Analytics, Intelligence, Platform

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution. The company's platform consists of various functional areas, such as sales, marketing, clinical research and product development, strategy, talent acquisition, and physician network management. It serves biopharmaceutical and medical device companies, healthcare information technology companies, and healthcare providers; and other diversified companies comprising staffing and commercial real estate firms, financial institutions, and other organizations in the healthcare ecosystem. Definitive Healthcare Corp. was founded in 2011 and is headquartered in Framingham, Massachusetts. Web URL: https://www.definitivehc.com

Additional Sources for DH Stock

DH Stock Overview

Market Cap in USD 515m
Sector Healthcare
Industry Health Information Services
GiC Sub-Industry Health Care Technology
IPO / Inception 2021-09-15

DH Stock Ratings

Growth 5y -89.2%
Fundamental -10.8%
Dividend -
Rel. Strength Industry -1188
Analysts 3.54/5
Fair Price Momentum 2.41 USD
Fair Price DCF 11.11 USD

DH Dividends

No Dividends Paid

DH Growth Ratios

Growth Correlation 3m 27.8%
Growth Correlation 12m -88.8%
Growth Correlation 5y -96.8%
CAGR 5y -50.98%
CAGR/Mean DD 5y -0.72
Sharpe Ratio 12m -1.10
Alpha -102.86
Beta 1.91
Volatility 51.92%
Current Volume 852.7k
Average Volume 20d 518k
What is the price of DH stocks?
As of December 22, 2024, the stock is trading at USD 4.18 with a total of 852,709 shares traded.
Over the past week, the price has changed by -6.90%, over one month by +1.95%, over three months by -7.11% and over the past year by -56.00%.
Is Definitive Healthcare a good stock to buy?
Neither. Based on ValueRay Fundamental Analyses, Definitive Healthcare is currently (December 2024) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of -10.79 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of DH as of December 2024 is 2.41. This means that DH is currently overvalued and has a potential downside of -42.34%.
Is DH a buy, sell or hold?
Definitive Healthcare has received a consensus analysts rating of 3.54. Therefor, it is recommend to hold DH.
  • Strong Buy: 4
  • Buy: 0
  • Hold: 8
  • Sell: 1
  • Strong Sell: 0
What are the forecast for DH stock price target?
According to ValueRays Forecast Model, DH Definitive Healthcare will be worth about 2.7 in December 2025. The stock is currently trading at 4.18. This means that the stock has a potential downside of -35.65%.
Issuer Forecast Upside
Wallstreet Target Price 5.3 26.3%
Analysts Target Price 12.5 197.8%
ValueRay Target Price 2.7 -35.6%